Introduction
Mechanisms of protein drug binding
Kinetics of protein drug binding
Classes of protein drug binding.
1. Binding of drug to blood components.
(a) Plasma proteins
(b) Blood cells
2. Binding of drug to extravascular tissue protein
Determination of Protein-drug Binding
Factors affecting protein drug binding
Significance of protein/tissue binding of drug
The phenomenon of complex formation of drug with protein is called as Protein drug binding. The proteins are particularly responsible for such an interaction. A drug can interact with several tissue components.
Introduction
Mechanisms of protein drug binding
Kinetics of protein drug binding
Classes of protein drug binding.
1. Binding of drug to blood components.
(a) Plasma proteins
(b) Blood cells
2. Binding of drug to extravascular tissue protein
Determination of Protein-drug Binding
Factors affecting protein drug binding
Significance of protein/tissue binding of drug
The phenomenon of complex formation of drug with protein is called as Protein drug binding. The proteins are particularly responsible for such an interaction. A drug can interact with several tissue components.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsRam Kanth
Greetings!
Good Day to all...
Topic: Methods of Enhancing Bioavailability
Several approaches discussed are
1. Micrnoization
2. Use of Surrfactants
3. Use of Salt forms
4. Alteration of pH of microenvironment
5. Use of metastable polymorphs
6. Solute-Solvent Complexation
7. Solvent Deposition
8. Selective Adsorption on Insoluble Carriers
9. Solid Solutions
10. Eutectic Mixtures
11. Solid Dispersions
12. Molecular Encapsulation with Cyclodextrins
Please do clarify for doubts if any....
Thank you all for watching this presentation.
It is defined as “the predictive mathematical model that describes the relationship between in vitro property (such as rate & extent of dissolution) of a dosage form and in vivo response (such as plasma drug concentration or amount of drug absorbed)”.
KINETICS OF MULTIPLE DOSING under the Unit Multicompartment Models According to New PCI syllabus 2017 by Ms. Preeti Patil-Vibhute, Assistant Professor, Sarojini College of Pharmacy, Kolhapur.
factors affecting protein drug binding
significance of protein binding
drug related factors
protein related factors
drug interactions
patient related factors
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsRam Kanth
Greetings!
Good Day to all...
Topic: Methods of Enhancing Bioavailability
Several approaches discussed are
1. Micrnoization
2. Use of Surrfactants
3. Use of Salt forms
4. Alteration of pH of microenvironment
5. Use of metastable polymorphs
6. Solute-Solvent Complexation
7. Solvent Deposition
8. Selective Adsorption on Insoluble Carriers
9. Solid Solutions
10. Eutectic Mixtures
11. Solid Dispersions
12. Molecular Encapsulation with Cyclodextrins
Please do clarify for doubts if any....
Thank you all for watching this presentation.
It is defined as “the predictive mathematical model that describes the relationship between in vitro property (such as rate & extent of dissolution) of a dosage form and in vivo response (such as plasma drug concentration or amount of drug absorbed)”.
KINETICS OF MULTIPLE DOSING under the Unit Multicompartment Models According to New PCI syllabus 2017 by Ms. Preeti Patil-Vibhute, Assistant Professor, Sarojini College of Pharmacy, Kolhapur.
factors affecting protein drug binding
significance of protein binding
drug related factors
protein related factors
drug interactions
patient related factors
Protein Binding of Drugs by Dr. Sanaullah AslamSanaullah Aslam
Your Feedback will be highly appreciated regarding "Protein Binding by Dr. Sanaullah Aslam". In this presentation protein binding of drugs is discussed in such a way that it could be easily understood by students of healthcare system.
Drug food interactions in details - QAQussai Abbas
Drug interactions (DIs) represent an important and widely under recognized source of medication errors. Interactions between food and drugs may inadvertently reduce or increase the drug effect. Some commonly used herbs, fruits as well as alcohol may cause failure of the therapy up a point of to serious alterations of the patient’s health. The majority of clinically relevant food-drug interactions are caused by food induced changes in the bioavailability of the drug. Major side-effects of some diet (food) on drugs include alteration in absorption by fatty, high protein and fiber diets.
Underlying factors:
Classification of drug-food interactions:
Pharmacodynamic interactions
Pharmacokinetic interactions
I. Absorption interactions
II. Transport and distribution interactions
III. Metabolism interactions
IV. Excretion interactions
Grapefruit juice
Alcohol and Medication Interactions
Common Alcohol-Medication Interactions
Specific Alcohol-Medication Interactions
Drug-drug interactions(DDI) are one of the commonest causes of medication error, particularly in the elderly due to poly-therapy, with a prevalence of 20-40%. Drug interactions represent factors of uncertainty in many therapeutic situations. Drug–drug interactions can cause profound clinical effects, either by reducing therapeutic efficacy or enhancing toxicity of drugs. With an increasing frequency in polypharmacy, DDIs are one of the major causes for drug withdrawal from the market. In particular, poly-therapy increases the complexity of therapeutic management and thereby the risk of clinically important DDIs, which can both induce the development of adverse drug reactions or reduce the clinical efficacy. Although DDIs can result in alterations of either drug pharmacokinetics (PK), pharmacodynamics(PD), or both, it is the pharmacokinetic drug interactions that is clinically significant. PK drug interactions, typically characterized by alterations of plasma concentration–time profiles, could be attributed to changes in processes of absorption, distribution, metabolism, and excretion of a drug substance mediated by another drug when they are given concomitantly. In this review we mainly focused on the pharmacokinetic drug interactions with various drug examples and their mechanism of drug interactions that are clinically significant.
Dissolution, factors affecting drug dissolution, methods to evaluate dissolution, advantages and disadvantages, recent approaches--these are the topics covered in this presentation.
Various insulin pumps used to deliver insulin to the human body and its application along with its advantages and disadvantages are outlined in this presentation.
Various approaches to Targeted Drug Delivery Systems (TDDS) in its formuation and evaluation in a pharmaceutical industry and research is outlined in this presentation.
This slide outlines the evaluation methods of various Controlled Drug Delivery Systems (CDDS) used in the pharmaceutical industry. The controlled Drug Delivery Systems release the drug to the plasma at a controlled, pre-determined level to ensure prolonged and adequate drug supply for a longer time. The slide analyses the various evaluation methods, its pharmacokinetic properties and applications of the evaluation methods in various scenario.
Bioequivalence studies for various pharmaceutical drug formulations manufactured and released into the market is outlined in this presentation. The various studies used to establish bioequivalency with the original formulation is also mentioned.
Applications of IR (Infrared) Spectroscopy in Pharmaceutical Industrywonderingsoul114
Various applications of IR (Infrared) Spectroscopy in Pharmaceutical industries related to drug discovery and structural elucidation is outlined in this presentation. Various qualitative and quantitative analysis of drug products are also outlined.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
How to Split Bills in the Odoo 17 POS ModuleCeline George
Bills have a main role in point of sale procedure. It will help to track sales, handling payments and giving receipts to customers. Bill splitting also has an important role in POS. For example, If some friends come together for dinner and if they want to divide the bill then it is possible by POS bill splitting. This slide will show how to split bills in odoo 17 POS.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
The Indian economy is classified into different sectors to simplify the analysis and understanding of economic activities. For Class 10, it's essential to grasp the sectors of the Indian economy, understand their characteristics, and recognize their importance. This guide will provide detailed notes on the Sectors of the Indian Economy Class 10, using specific long-tail keywords to enhance comprehension.
For more information, visit-www.vavaclasses.com
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Unit 8 - Information and Communication Technology (Paper I).pdf
Factors Affecting Protein-Binding of Drugs
1. SEMINAR PRESENTATION
TOPIC: FACTORS AFFECTING PROTEIN-
BINDING OF DRUGS
Subject in-charge:
Mr. Mohammed Haneefa
Associate Prof. & Vice
Principal
Dept. of Pharmaceutics
Al Shifa College of
Pharmacy
Presented by:
Muhammed Fahad
1st MPharm Pharmaceutics
(3rd Batch)
Al Shifa College of
Pharmacy
2. FACTORS AFFECTING
PROTEIN BINDING OF DRUGS
1. Factors relating to the drug
2. Factors relating to the protein and other
binding component
3. Drug interactions
4. Patient related factors
2
3. 1. DRUG RELATED FACTORS
Physicochemical Characteristics of the Drug
Increase in lipophilicity increases the extend of binding.
E.g. Cloxacillin 95% bound, Ampicillin 20% bound;
hence Cloxacillan is released slowly after i.m. injection.
Acidic/anionic drugs bind to HSA; basic/cationic drugs
to AAG; neutral/unionized drugs to lipoproteins.
3
4. Concentration of Drug in the Body
At low concentrations,
most drugs may be bound
to proteins
At high concentrations,
more free drugs may be
present owing to
saturation of binding sites
on protein
4
Figure : Fraction of drug bound versus drug
concentration at constant protein concentration
5. Drug-Protein/Tissue Affinity
Lidocaine has greater affinity for AAG than for
HSA.
Digoxin has more affinity for proteins of cardiac
muscles than those of skeletal muscles or
plasma.
Iophenoxic acid has half life of 2 ½ yrs due to its
high affinity to plasma proteins.
5
6. 2. PROTEIN RELATED FACTORS
Physicochemical Properties of Protein/Binding
Component
Lipophilicitylipoproteins bind with lipophilic drugs.
Albumindepend on physiological pH.
Concentration of Protein/Binding Components
Disease states affect the concentration of proteins
in blood.
6
7. Effect of protein concentration on the percentage of
drug bound. A, B, and C represent hypothetical drugs
with respectively decreasing binding affinity
7
8. Number of Binding Sites on the Protein
Albumin has a large number of binding sites as
compared to other proteins.
Indomethacin binds to 3 sites on albumin.
AAG is a protein with limited binding capacity due
to low concentration & molecular size.
Lidocaine binds to 2 sites on AAG in presence of
HSA.
8
9. 3. DRUG INTERACTIONS
Displacement
Interactions
Competition between
Drugs for the Binding
Sites.
e.g. warfarin and
phenyl butazone
9
10. Interactions will result when:
The displaced drug (E.g. warfarin)—
is more than 95% bound
has a small volume of distribution
shows a rapid onset of therapeutic or adverse effects
has a narrow therapeutic index
The displacer drug (E.g. phenyl butazone)—
has a high degree of affinity as the drug to be
displaced
competes for the same binding sites
the drug/protein concentration ratio is high
shows a rapid and large increase in plasma drug
concentration
10
11. Competition between Drugs and Normal Body
Constituents:
Interaction with free fatty acids.
Free fatty acid levels are increased during
fasting, diabetes, MI, etc.
Eg.: Interaction of sod. salicylate with bilirubin in
neonates.
11
12. Allosteric Changes in Protein Molecule:
involves alteration of the protein structure by the
drug/metabolite modify binding capacity.
Eg.: Aspirin acetylation of albumin; modify the
binding capacity of NSAIDs (increased affinity).
12
13. 4. PATIENT RELATED FACTORS
Age:
Neonates
Change in albumin content affects the drugs
binding to it.
Infants
Elderly
Intersubject Variations:
Disease States:
Hypoalbuminemia severely impair protein-drug
binding.
13
16. REFERENCE:
Leon Shargel, Applied Biopharmaceutics and
Pharmacokinetics, 5th edition,Chapter: Physiologic Drug
Distribution and Protein Binding.
P.L.Madan, Biopharmaceutics and Pharmacokinetics,
1st editoin, p 82-85.
D.M.Brahmankar, Biopharmaceutics and
Pharmacokinetics—A Treatise, 1st edition, p 97-102.
G.R.Chatwal, Biopharmaceutics and
Pharmacokinetics, 1st edition, p 55-58.
Milo Gibaldi, Biopharmaceutics and Clinical
Pharmacokinetics, 4th edition, p 195-200.
16
17. REFERENCE:
Javed Ali, A Textbook of Biopharmaceutics and
Pharmacokinetics, 1st edition, p 51-53.
H.P Tripnis, Amritha Bajaj, Principles and Applications
of Biopharmaceutics and Pharmacokinetics, 1st edition,
p 73-79.
V. Venkateswarlu, Fundamentals of Biopharmaceutics
and Pharmacokinetics, 1st edition, p 68-71.
Shobha Rani, Textbook of Biopharmaceutics and
Pharmacokinetics, 1st edition, p 142-143.
17
Factors Affecting Protein Binding 1. Factors relating to the druga. Physicochemical characteristics of the drugb. Concentration of the drug in the bodyc. Affinity of a drug for a particular binding component2. Factors relating to the protein and other binding componenta. Physicochemical characteristics of the protein or binding agentb. Concentration of protein or binding componentc. Number of binding sites on the binding agent3. Drug interactionsa. Competition between drugs for the binding site (displacement interactions)b. Competition between drugs and normal body constituentsc. Allosteric changes in protein molecule4. Patient related factorsa. Ageb. Intersubject variationsc. Disease states
DRUG RELATED FACTORSPhysicochemical Characteristics of the DrugProtein binding is directly related to the lipophilicity of the drug. An increase in lipophilicity increases the extend of binding; for example, the slow absorption of cloxacillin in comparison to ampicillin after i.m. injection is attributed to its higher lipophilicity and larger (95%) binding to proteins while the latter is less lipophilic and just 20% bound to proteins. Highly lipophilic drugs such as thiopental tend to localize in adipose tissues. Anionic or acidic drugs such as penicillins and sulphonamides bind more to HSA whereas cationic or basic drugs such as imipramine and alprenolol bind to AAG. Neutral, unionized drugs bind more to lipoproteins.
Concentration of Drug in the BodyThe extend of protein-drug binding can change with both changes in drug as well as protein concentration. The concentration of drugs that bind to HSA does not have much of an influence as the therapeutic concentration of any drug is insufficient to saturate it. However, therapeutic concentration of lidocaine can saturate AAG with which it binds as the concentration of AAG is much less in comparison to that of HSA in blood. With a constant concentration of protein, only a certain number of binding sites are available for a drug. At low drug concentrations, most of the drug may be bound to the protein, whereas at high drug concentrations, the protein-binding sites may become saturated, with a consequent rapid increase in the free drug concentrations.
Drug-Protein/Tissue AffinityLidocaine has greater affinity for AAG than for HSA. Digoxin has more affinity for proteins of cardiac muscles than those of skeletal muscles or plasma. Iophenoxic acid, a radio opaque medium, has so great an affinity for plasma proteins that it has a half life of 2 ½ years.
PROTEIN/TISSUE RELATED FACTORSPhysicochemical Properties of Protein/Binding ComponentLipoproteins and adipose tissue tend to bind lipophilic drugs by dissolving them in their lipid core. The physiologic pH determines the presence of active anionic and cationic groups on the albumin molecules to bind to a variety of drugs. Concentration of Protein/Binding ComponentsAmong the plasma proteins, binding predominantly occurs with albumin as it is present in a higher concentration in comparison to other plasma proteins. The amount of several proteins and tissue components available for binding, changes during disease states. As the protein concentration increases, the percent of drug bound increases to a maximum. The shapes of the curves are determined by the association constant of the drug–protein complex and the drug concentration.
The effect of protein concentration on drug binding is demonstrated in Figure.
Number of Binding Sites on the ProteinAlbumin has a large number of binding sites as compared to other proteins and is a high capacity binding component. Several drugs are capable of binding at more than one site on albumin, example flucocloxacillin, flurbiprofen, ketoprofen, tamoxifen and dicoumarol bind to both primary and secondary sites on albumin. Indomethacin is known to bind to 3 different sites. AAG is a protein with limited binding capacity because of its low concentration and low molecular size. Though pure AAG has only one binding site for lidocaine, in presence of HSA, two binding sites have been reported which was suggested to be due to direct interaction between HSA and AAG.
DRUG INTERACTIONSCompetition between Drugs for the Binding Sites (Displacement Interactions)When two or more drugs can bind to the same site, competition between them for interaction with the binding site occurs. If one of the drugs (drug A) is bound to such a site, then administration of another drug (drug B) having affinity for the same site results in displacement of drug A from its binding site. Such a drug-drug interaction for the common binding site is called as displacement interaction.The drug A is called the displaced drug and drug B is called displacer.Example: Warfarin and phenyl butazone have same degree of affinity for HSA. Administration of phenyl butazone to a patient on warfarin therapy results in displacement of latter from its binding site. The free warfarin may cause adverse hemorrhagic reactions which may be lethal. Phenyl butazone is also known to displace sulphonamides from their HSA binding sites. Displacement interactions can result in unexpected rise in free concentration of the displaced drug which may enhance clinical response or toxicity. Even a drug metabolite can affect displacement interaction.
Clinically significant interactions will result when:The displaced drug (E.g. warfarin)—is more than 95% boundhas a small volume of distribution (less than 0.15 L/Kg)shows a rapid onset of therapeutic or adverse effectshas a narrow therapeutic indexThe displacer drug (e.g. phenyl butazone)—has a high degree of affinity as the drug to be displacedcompetes for the same binding sitesthe drug/protein concentration ratio is high (above 0.10)shows a rapid and large increase in plasma drug concentration It will be worthwhile to mention here that both the concentration of the displacer drug and its affinity for the binding site with respect to that of the drug to be displaced will determine the extent to which displacement will occur.For a drug that is 95% bound a displacement of just 5% of the bound drug results in a 100% rise in free drug concentration. If the displaced drug has a small volume of distribution, it remains confined to the blood compartment and shows serious toxic responses. On the contrary, if such a drug has a large volume of distribution, it redistributes into a large volume of body fluids and clinical effects may be negligible or insignificant. The increase in free drug concentration following displacement also makes it more available for elimination by the liver and the kidneys (Figure 4). If the drug is easily metabolizable or excretable, its displacement results in significant reduction in elimination half life.Displacement also becomes insignificant with the use of more selective, potent, low dose drugs.
Competition between Drugs and Normal Body Constituents:Among the various normal body constituents, the free fatty acids are known to interact with a number of drugs that bind primarily to HSA. The free fatty acid level is increased in several physiologic (fasting), pathologic (diabetes, myocardial infarction, alcohol abstinence) and pharmacologically induced conditions (after heparin and caffeine administration). The fatty acis, which also bind to albumin, influence binding of several enzodiazepines and propranolol (decreased binding) and warfarin (increased binding). Bilirubin binding to HSA can be impaired by certain drugs and is of great concern in neonates whose BBB and bilirubin metabolizing capacity are not very efficient. Acidic drugs such as sodium salicylate, sodium benzoate and sulfonamides displace bilirubin from its albumin binding site. The free bilirubin is not conjugated by the liver of the neonates and thus crosses the BBB and precipitates the condition called as kernicterus (characterized by degeneration of brain and mental retardation). Allosteric Changes in Protein Molecule:This is yet another mechanism by which drugs can affect protein binding interactions. The process involves alteration of the protein structure by the drug or its metabolite thereby modifying its binding capacity. The agent that produces such an effect is called as allostericeffector. Example: aspirin acetylates the lysine fraction of albumin thereby modifying its capacity to bind NSAIDs like phenyl butazone (increased affinity) and flufenamic acid (decreased affinity).
PATIENT RELATED FACTORS Age: Modification in protein-drug binding as influenced by age of the patient is mainly due to differences in the protein content in various age groups. Neonates:Albumin content is low in new born; as a result, the unbound concentration of drug that predominantly bind to albumin (e.g. phenytoin and diazepam) is increased. Young infants:An interesting example of differences in protein-drug binding in infants is that of digoxin. Infants suffering from congestive cardiac failure are given a digitalizing dose 4-6 times the adult dose on body weight basis. This is contrary to the general belief that infants should be given low doses considering their poorly developed eliminatory system. The reason attributed for use of a large digoxin dose is greater binding of the drug in infants (the other reason is abnormally large renal clearance of digoxin in infants). Elderly:In old age, the albumin content is lowered and free concentration of drugs that bind primarily to it is increased. Old age is also characterized by an increase in the levels of AAG and thus decreased free concentration is observed for drugs that bind to it. The situation is complex and difficult to generalize for drugs that bind to both HSA and AAG, e.g. lidocaine and propranolol Intersubject Variations: Intersubject variations in drug binding as studied with few drugs showed that the difference is small and no more than two fold. These differences have been attributed to genetic and environmental factors. Disease States: Several pathologic conditions are associated with alteration in protein content. Since albumin is the major drug binding protein, hypoalbuminemia can severely impair protein-drug binding. Hypoalbuminemia is caused by several conditions like aging, CCF, trauma, burns, inflammatory states, renal and hepatic disorders, pregnancy, surgery, cancer, etc. Almost every serious chronic illness is characterized by decreased albumin content. Some of the diseases that modify protein-drug binding are depicted in Table 4. Hyperlipoproteinemia caused by hypothyroidism, obstructive liver disease, alcoholism, etc. affects binding of lipophilic drugs.
Putting in a nutshell, all factors, especially drug interactions and patient related factors that affect protein or tissue binding of drugs, influence: Pharmacokinetics of drugs: A decrease in plasma protein-drug binding i.e. an increase in unbound drug concentration, favours tissue redistribution and/or clearance of drugs from the body (enhanced biotransformation and excretion).Pharmacodynamics of drugs: An increase in concentration of free or unbound drug results in increased intensity of action (therapeutic/toxic).